Four cities construct consortium for genomic surveillance of virus


TO COMPLEMENT the nationwide effort led by Indian SARS-CoV-2 Consortium on Genomics (INSACOG), a consortium of 4 metropolis clusters – Bengaluru, Hyderabad, New Delhi and Pune – has been established to upscale genomic surveillance on SARS-CoV-2, the virus that causes Covid-19. The new effort goals at creating methods and constructing capabilities to establish variants of concern earlier than they unfold extensively and trigger outbreaks, mentioned consultants.

The consortium goals to develop focused sampling methods based mostly on granular epidemiological and scientific information. Coupled with intense environmental surveillance and superior computational strategies, the consortium may even concentrate on constructing capabilities for real-time surveillance and epidemiology, learn an official assertion issued on Thursday.

The consortium has been established with the assist and seed funding of Rockefeller Foundation, and is led by CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad. At current, it consists of totally different companions in three different cities: NCBS-TIFR, InStem-DBT and NIMHANS in Bengaluru; CSIR-IGIB in New Delhi; Pune Knowledge Cluster, CSIR-NCL and IISER in Pune. It will work intently with native governments, hospitals and clinicians. In collaboration with INSACOG, the consortium goals to ultimately flip this right into a nationwide effort by increasing to different strategic places in India.

Dr Rakesh Mishra, adviser at CSIR-CCMB, will lead these efforts together with Prof Satyajit Mayor, NCBS; Prof L S Shashidhara, Pune Knowledge Cluster; and Dr Anurag Agrawal, CSIR-IGIB.


Leave a Reply

Your email address will not be published.

Back to top button

Adblocker detected! Please consider reading this notice.

We've detected that you are using AdBlock Plus or some other adblocking software which is preventing the page from fully loading. We don't have any banner, Flash, animation, obnoxious sound, or popup ad. We do not implement these annoying types of ads! We need money to operate the site, and almost all of it comes from our online advertising. Please add to your ad blocking whitelist or disable your adblocking software.